🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚀 Kick-off der #SGLT2HYPE-Studie! Heute startete am Universitätsklinikum Schleswig-Holstein unter Prof. Ingo Eitel das EU-Großprojekt mit 3.000+ Patienten. Ziel: Den Nutzen des SGLT2-Hemmers Dapagliflozin für die Herz-Kreislauf- und Nierengesundheit zu erforschen. ➡️herzmedizin.de/fuer-aerzte-un… #Herzmedizinde

🔬 SGLT2 HYPE Mission: Tackling #hypertension by investigating SGLT2 inhibitors to improve blood pressure control and reduce cardiovascular & kidney risks. Empowering patients with innovative treatments. #Hypertension #SGLT2 #CardiovascularHealth #HorizonEU #Health

🫀At the Universitätsklinikum Schleswig-Holstein Health Forum, Elias Rawish shared insights on hypertension and its treatment. Patients showed great interest in the promising @SGLT2 HYPE Project! For more event info: shorturl.at/ISbhh #Hypertension #SGLT2 #CardiovascularHealth #HorizonEU #Health

🔬 The vision of SGLT2 HYPE is reimagining #Hypertension care with SGLT2 inhibitors like Dapagliflozin—protecting the 💓 heart, 🧠 brain, 🩺 kidneys, and 🩸 vessels, improving lives & saving billions. #SGLT2 #CardiovascularHealth #HorizonEU #Health

#Hypertension is a silent killer. It forces the heart to work harder, damaging blood vessels and organs over time. The SGLT2 HYPE project is tackling resistant hypertension with new, innovative SGLT2 HYPE i to save lives across Europe. #CardiovascularHealth #HorizonEU #Health

🎯 “The SGLT2 HYPE study offers a unique opportunity to generate new, evidence-based insights for hypertension treatment. It has the potential to provide millions of patients with a safer and more effective therapy.” – Prof. Ingo Eitel #CardiovascularHealth #HorizonEU #Health

Great exchange at the #DGK2025 in Mannheim! 🚀 The SGLT2 HYPE Coordinator hosted a joint meeting with investigators across projects – aligning efforts, sharing insights & planning next steps. Synergies in action! 💡🫀 #SGLT2_HYPE #CardioResearch #HorizonEU #Collaboration

🩺 17th May: It’s #WorldHypertensionDay! SGLT2 HYPE is an European study evaluating dapagliflozin in 3,200 adults with uncontrolled hypertension & CV risk. Over 7 years, it will track heart & kidney outcomes—shaping the future of hypertension treatment. sglt2-hype.eu

🌍 Join today the #ICTD2025, Madrid, online! Theme: Inclusivity in Clinical Research 🔗 ecrin.org/ictd-2025 📌 Patients, ethicists, regulators&industry unite to rethink inclusion 💬 Panels, use cases, EU projects & more! #ClinicalTrials #HealthEquity #HorizonEU #PatientVoice

🫀 Save the date: 6th European Summit on Cardiology Research! 🗓 Rome, May 26–27, 2025 🔬 Cutting-edge science, expert insights & global networking 🔗 shorturl.at/sc95d Let’s shape the future of cardiovascular health together. #CardiologySummit2025 #CardiovascularResearch

📊 WP2 powers the digital core of SGLT2 HYPE : secure data, smart randomisation, EU-wide CEA & DICOM transfer! Led by Universitätsklinikum Schleswig-Holstein 💻🔍 #ClinicalTrials #DigitalHealth #Hypertension #eHealth

🚨 New Interview! Coordinors Ingo Eitel & Elias Rawish on the EU-funded #SGLT2Hype study exploring new ways to treat #hypertension. Watch now (in german) 🎥👉sglt2-hype.eu #SGLT2HYPE #HeartHealth #ClinicalTrials #EUresearch #Dapagliflozin

🧪 WP4 is building the biobanking backbone of #SGLT2HYPE! SOPs + training = harmonised, high-quality blood sample handling across all sites. Led by Inserm . #ClinicalResearch #Biobanking #SGLT2HYPE #HeartHealth #ClinicalTrials #EUresearch #Dapagliflozin

📊 WP5 ensures statistical integrity in #SGLT2HYPE – from protocol design to randomisation & analysis. Led by IHF, it’s the backbone of reliable, trustworthy trial results. #ClinicalTrials #HorizonEU #SGLT2HYPE #HeartHealth #EUresearch #Dapagliflozin

💊 WP6 of SGLT2 HYPE ensures patient enrolment, safe investigational medicinal products distribution, regular visits & echo assessments—led by Universitätsklinikum Schleswig-Holstein , it's key to trial success! 🫀📦 #SGLT2HYPE #HeartHealth #ClinicalTrials #EUresearch #Dapagliflozin

🔍 WP7 ensures safety, compliance & FAIR data in SGLT2 HYPE ! 👉Safety monitoring, risk-based checks, secure IT & open access. Led by @uksh_de 🛡️ #HorizonEU #ClinicalTrials #CardioCare #HeartHealth #ClinicalTrials #EUresearch #Dapagliflozin

📊 WP8, led by the Institut für Herzinfarktforschung = the stats engine of the SGLT2 HYPE trial! From interim safety checks 🛡️ to final data analysis 📈 & evidence sharing 🔬—ensuring rigour, safety & impact. #Health #Hypertension #SGLT2 #CardiovascularHealth #HorizonEU

💶 WP9 links trial data to cost-effectiveness 📊 via Markov models, DALYs & ICERs 💡 for smart EU health policy. Led by Universitätsklinikum Schleswig-Holstein . #Health #Hypertension #SGLT2 #CardiovascularHealth #HorizonEU

📊 WP10 in #SGLT2HYPE dives into sex & sociodemographic factors in SGLT2i response 💡 Led by Institut für Herzinfarktforschung in Ludwigshafen, it drives data-driven, equitable care in #ClinicalTrials 💊 #HeartHealth #EUresearch #Dapagliflozin

🔬 What makes SGLT2 inhibitors effective in treating hypertension? WP11 of #SGLT2HYPE, led by Universidade Porto , explores this via advanced biomarker analysis, biobanking, and bioinformatics—paving the way for precision medicine in HTN. 💡🧬 #HorizonEurope #Hypertension